{"schemaVersion":"1.0.0","generatedAt":"2026-07-20T17:20:35.764Z","identity":{"ticker":"ACRV","name":"Acrivon Therapeutics, Inc.","cik":"0001781174","exchange":"Nasdaq","sector":"Healthcare","kind":"equity","tier":3,"liquidityRank":4535,"liquidityObservedAt":"2026-07-18T03:07:41.953Z","liquidityDollarVolume":418055.75,"liquidityLastSale":1.75,"liquidityShareVolume":238889,"marketCap":74903026,"isUsListed":true,"sourceIds":["sec-tickers","nasdaq-symbol-directory","nasdaq-screener"]},"quote":{"last":1.75,"previousClose":1.75,"change":0,"changePct":0,"currency":"USD","volume":238889,"observedAt":"2026-07-18T03:07:41.953Z"},"fundamentals":{"ticker":"ACRV","cik":"0001781174","annual":{"revenue":null,"dilutedEps":{"value":-2.02,"start":"2025-01-01","end":"2025-12-31","period":"CY2025","accessionNumber":"0001193125-26-115123","filingUrl":"https://www.sec.gov/Archives/edgar/data/1781174/000119312526115123/0001193125-26-115123-index.html","concept":"EarningsPerShareDiluted","unit":"USD-per-shares","sourceUrl":"https://data.sec.gov/api/xbrl/frames/us-gaap/EarningsPerShareDiluted/USD-per-shares/CY2025.json"}},"quarterly":{"revenue":null,"dilutedEps":{"value":-0.49,"start":"2026-01-01","end":"2026-03-31","period":"CY2026Q1","accessionNumber":"0001193125-26-221634","filingUrl":"https://www.sec.gov/Archives/edgar/data/1781174/000119312526221634/0001193125-26-221634-index.html","concept":"EarningsPerShareDiluted","unit":"USD-per-shares","sourceUrl":"https://data.sec.gov/api/xbrl/frames/us-gaap/EarningsPerShareDiluted/USD-per-shares/CY2026Q1.json"}}},"dividends":[],"seasonality":[],"news":[],"provenance":{"registry":"/data/machine/v1/universe/registry.json","framesGeneratedAt":"2026-07-16T23:27:27.036Z","quoteSourceUrl":"https://www.nasdaq.com/market-activity/stocks/screener","methodologyUrl":"https://dhawal.org/methodology/#coverage-tiers"},"limitations":["Directory treatment","Frame facts may be absent","No options or analyst estimates"]}